Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Evozyne
AddedFeb 15, 2024
UpdatedJun 18, 2026
Evozyne

Evozyne

Series B

Evozyne: Merging evolution and AI to amplify protein functions for therapeutics and sustainability solutions.

HQ
Chicago, IL, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Evozyne, founded with a mission to leverage evolutionary biology and artificial intelligence, focuses on creating novel proteins to address critical challenges in therapeutics and sustainability. Their core technology, Natural Machines™, amplifies protein functions based on natural principles, offering innovative solutions for complex, high-impact problems. Evozyne's market focus includes pharmaceutical companies seeking advanced therapeutic proteins and industries aiming for sustainable biotechnological applications.

Notable affiliated individuals and investors include leaders in biotechnology and AI, although specific names are not provided. Evozyne has achieved significant milestones in developing proteins with enhanced functionalities, contributing to advancements in both healthcare and environmental sustainability. The company's impact is marked by its pioneering approach, merging evolution with deep learning to produce groundbreaking protein systems that promise a healthier world.

Evozyne - Similar Companies

Evozym Biologics logo

Evozym Biologics

AI Proteins logo

AI Proteins

aiproteinstx.com

Profluent Bio logo

Profluent Bio

profluent.bio

20n logo

20n

Generate Biomedicines logo

Generate Biomedicines

EvoAktiv logo

EvoAktiv

evoagtec.com

Protein Evolution logo

Protein Evolution

Regenerative Bio logo

Regenerative Bio

regen-bio.us

1910 logo

1910

1910genetics.com

Enveda Biosciences logo

Enveda Biosciences

envedabio.com

Manifold Bio logo

Manifold Bio

manifold.bio

EVQLV logo

EVQLV

evqlv.com

NeuroX1 logo

NeuroX1

neurox1.com

Evolv AI logo

Evolv AI

evolv.ai

Nabla Bio logo

Nabla Bio

nabla.bio

Evozyne - Quick Facts

Who are Evozyne's competitors?

Companies similar to Evozyne include Evozym Biologics, AI Proteins, Profluent Bio and 20n.

When was Evozyne founded?

Evozyne was founded in 2020.

Where is Evozyne's headquarters located?

Evozyne's headquarters is located in Chicago, IL, US.

When was Evozyne's last funding round?

Evozyne's most recent funding round was for $81M (USD) in September 2023.

How much has Evozyne raised to-date?

As of Sep 27, 2023, Evozyne has raised a total of $144.4M (USD).

How many employees does Evozyne have?

Evozyne has 175 employees as of Feb 5, 2024.

Evozyne - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Protein Engineering
Tags
  • AI Operations
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified